These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35613745)

  • 1. "Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives". Sara Tomassetti, Venerino Poletti, Claudia Ravaglia, Nicola Sverzellati, Sara Piciucchi, Diletta Cozzi, Valentina Luzzi, Camilla Comin and Athol U. Wells.
    Eur Respir Rev; 2022 Jun; 31(164):. PubMed ID: 35613745
    [No Abstract]   [Full Text] [Related]  

  • 2. Erratum: "Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges". Namrata Kewalramani, Carlos Machahua, Venerino Poletti, Jacques Cadranel, Athol U. Wells and Manuela Funke-Chambour.
    ERJ Open Res; 2022 Jul; 8(3):. PubMed ID: 36199387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Intersections of lung progenitor cells, lung disease and lung cancer." Carla F. Kim.
    Eur Respir Rev; 2017 Dec; 26(146):. PubMed ID: 29070583
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of high-resolution computed tomography in the follow-up of diffuse lung disease: Number 2 in the Series "Radiology" Edited by Nicola Sverzellati and Sujal Desai.
    Elicker BM; Kallianos KG; Henry TS
    Eur Respir Rev; 2017 Jun; 26(144):. PubMed ID: 28615307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives.
    Tomassetti S; Poletti V; Ravaglia C; Sverzellati N; Piciucchi S; Cozzi D; Luzzi V; Comin C; Wells AU
    Eur Respir Rev; 2022 Jun; 31(164):. PubMed ID: 35418487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Lung biopsy in interstitial lung disease: balancing the risk of surgery and diagnostic uncertainty." Vincent Cottin. Eur Respir J 2016; 48: 1274-1277.
    Eur Respir J; 2016 Dec; 48(6):1819. PubMed ID: 27903698
    [No Abstract]   [Full Text] [Related]  

  • 7. Multidisciplinary evaluation of interstitial lung diseases: current insights: Number 1 in the Series "Radiology" Edited by Nicola Sverzellati and Sujal Desai.
    Walsh SLF
    Eur Respir Rev; 2017 Jun; 26(144):. PubMed ID: 28515041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis." Kevin R. Flaherty, Charlene D. Fell, J. Terrill Huggins, Hilario Nunes, Robert Sussman, Claudia Valenzuela, Ute Petzinger, John L. Stauffer, Frank Gilberg, Monica Bengus and Marlies Wijsenbeek.
    Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30287496
    [No Abstract]   [Full Text] [Related]  

  • 9. "Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis." Bridget F. Collins and Ganesh Raghu.
    Eur Respir Rev; 2019 Dec; 28(154):. PubMed ID: 31722893
    [No Abstract]   [Full Text] [Related]  

  • 10. "Desquamative interstitial pneumonia: a systematic review of its features and outcomes." Merel E. Hellemons, Catharina C. Moor, Jan von der Thüsen, Mariska Rossius, Arlette Odink, Laila Haugen Thorgersen, Johny Verschakelen, Wim Wuyts, Marlies S. Wijsenbeek and Elisabeth Bendstrup.
    Eur Respir Rev; 2020 Sep; 29(157):. PubMed ID: 32759375
    [No Abstract]   [Full Text] [Related]  

  • 11. "Idiopathic inflammatory myopathies and the lung." Jean-Christophe Lega, Quitterie Reynaud, Alexandre Belot, Nicole Fabien, Isabelle Durieu and Vincent Cottin. Eur Respir Rev 2015; 24: 216-238.
    Eur Respir Rev; 2015 Sep; 24(137):545. PubMed ID: 26324818
    [No Abstract]   [Full Text] [Related]  

  • 12. "Is bronchiectasis really a disease?" Michal Shteinberg, Patrick A. Flume and James D. Chalmers.
    Eur Respir Rev; 2020 Mar; 29(155):. PubMed ID: 32051170
    [No Abstract]   [Full Text] [Related]  

  • 13. "Cardiovascular disease and COPD: dangerous liaisons." Klaus F. Rabe, John R. Hurst and Samy Suissa.
    Eur Respir Rev; 2018 Dec; 27(150):. PubMed ID: 30463874
    [No Abstract]   [Full Text] [Related]  

  • 14. Erratum:
    ERJ Open Res; 2018 Jul; 4(3):. PubMed ID: 30117319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension." Irene M. Lang and Sean P. Gaine. Eur Respir Rev 2015; 24: 630-641.
    Eur Respir Rev; 2016 Mar; 25(139):99. PubMed ID: 26929428
    [No Abstract]   [Full Text] [Related]  

  • 16. "The therapy of idiopathic pulmonary fibrosis: what is next?" Vivien Somogyi, Nazia Chaudhuri, Sebastiano Emanuele Torrisi,
    Eur Respir Rev; 2019 Sep; 28(153):. PubMed ID: 31554706
    [No Abstract]   [Full Text] [Related]  

  • 17. "Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice." Stephen Y. Chan and Lewis J. Rubin.
    Eur Respir Rev; 2018 Mar; 27(147):. PubMed ID: 29367412
    [No Abstract]   [Full Text] [Related]  

  • 18. "Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension." Irene M. Lang, Sean P. Gaine. Eur Respir Rev 2015; 24: 630-641.
    Eur Respir Rev; 2017 Jan; 26(143):. PubMed ID: 28049123
    [No Abstract]   [Full Text] [Related]  

  • 19. "Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis." Vincent Cottin and Toby Maher. Eur Respir Rev 2015; 24: 58-64.
    Eur Respir Rev; 2015 Sep; 24(137):545. PubMed ID: 26324819
    [No Abstract]   [Full Text] [Related]  

  • 20. "Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis." Yasuhiro Kondoh, Vincent Cottin and Kevin K. Brown.
    Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29653947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.